BOLD - Audentes Therapeutics (BOLD) CEO Matthew Patterson on Q4 2018 Results - Earnings Call Transcript
Audentes Therapeutics (BOLD)
Q4 2018 Earnings Conference Call
February 27, 2019 04:30 PM ET
Company Participants
Andrew Chang - Director of Investor Relations
Matthew Patterson - President and Chief Executive Officer
Thomas Soloway - Senior Vice President and Chief Financial Officer
Natalie Holles - President and Chief Operating Officer
Conference Call Participants
Subbu Nambi - Cowen and Company
Anupam Rama - JPMorgan
Aspen Mori - Bank of America Merrill Lynch
Christopher Raymond - Piper Jaffray.
Dae Ha - SVB Leerink LLC
Evan Wang - Guggenheim Securities LLC
Raju Prasad - William Blair & Co.
Matthew